Indivior (LON:INDV) PT Lowered to GBX 1,500 at Deutsche Bank Aktiengesellschaft

Indivior (LON:INDV) had its target price cut by Deutsche Bank Aktiengesellschaft from GBX 2,350 ($30.10) to GBX 1,500 ($19.21) in a report released on Tuesday morning, Digital Look reports. They currently have a buy rating on the specialty pharmaceutical company’s stock.

Indivior Trading Up 3.8 %

LON:INDV traded up GBX 28.50 ($0.37) during trading hours on Tuesday, reaching GBX 785 ($10.06). The company’s stock had a trading volume of 27,709,025 shares, compared to its average volume of 721,224. The company has a debt-to-equity ratio of 2,790.00, a quick ratio of 1.52 and a current ratio of 0.93. The firm has a market capitalization of £1.06 billion, a price-to-earnings ratio of 26,233.33, a PEG ratio of -5.57 and a beta of 0.06. The firm has a 50-day simple moving average of GBX 1,323.63 and a 200-day simple moving average of GBX 1,420.38. Indivior has a 1 year low of GBX 653 ($8.36) and a 1 year high of GBX 1,938 ($24.82).

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.